Kymera Therapeutics (KYMR) P/E (2020 - 2026)
Kymera Therapeutics (KYMR) P/E from Sep 30, 2020 to Jul 21, 2026. The TTM Kymera Therapeutics (KYMR) P/E is -27.36. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Kymera Therapeutics (KYMR)
| Year | P/E | Change |
|---|---|---|
| 2026 | -27.36 | +51.50% |
| 2025 | -18.06 | +58.49% |
| 2024 | -11.40 | +35.53% |
| 2023 | -8.41 | -1.32% |
| 2022 | -8.52 | -72.48% |
| 2021 | -30.96 | -76.78% |
| 2020 | -133.32 | N/A |
Comparison Kymera Therapeutics (KYMR) P/E with competitors
Kymera Therapeutics (KYMR) P/E is -27.36.